The pharma is shaping its mRNA platform into prophylactic and cancer vaccines, as well as immuno-oncology, regenerative and systemic therapeutics.
The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgh5Za9VzDSIypC9-OqycoBczcPmfyYXDjY2QZ9TLZ_m014ujkZKIEpPHrUWgFXhGmFfrSdSXve7IcOJBSvItkNISz_wORJ1W-zs0QzUsABOj-RnajORmXdinxObQW5ldFYzgo-hQm2AXU/s400/MRNA-b.png)
Industry: Biotechnology
Headquarters: Cambridge, Massachusetts
Number of employees: ~700
Founded: 2010
http://www.modernatx.com
Offer size: $604 million; 21.7 million shares
No comments:
Post a Comment